Preclinical In-Vivo Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030

Preclinical In-Vivo Imaging Trends and Forecast

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

A more than 150-page report is developed to help in your business decisions.

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Optical Imaging
• Nuclear Imaging
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Research & Development
• Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Others

Preclinical In-Vivo Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preclinical in-vivo imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

• Bruker Corporation
• Siemens
• Trifoil Imaging
• Perkinelmer
• Visualsonics

Preclinical In-Vivo Imaging Market Insights

Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Within this market, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.

North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Features of the Global Preclinical In-Vivo Imaging Market

Market Size Estimates: Preclinical in-vivo imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the preclinical in-vivo imaging market size?

Answer: The global preclinical in-vivo imaging market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for preclinical in-vivo imaging market?

Answer: The global preclinical in-vivo imaging market is expected to grow with a CAGR of 6.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the preclinical in-vivo imaging market?

Answer: The major drivers for this market are growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

Q4. What are the major segments for preclinical in-vivo imaging market?

Answer: The future of the preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets.

Q5. Who are the key preclinical in-vivo imaging market companies?

Answer: Some of the key preclinical in-vivo imaging companies are as follows:

• Bruker Corporation
• Siemens
• TriFoil Imaging
• PerkinElmer
• VisualSonics

Q6. Which preclinical in-vivo imaging market segment will be the largest in future?

Answer: Lucintel forecasts that micro-ultrasound systems is expected to witness highest growth over the forecast period.

Q7. In preclinical in-vivo imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?